Randomized, Open-Label Study Of Bintrafusp Alfa Vs. Pembrolizumab As First-Line (1l) Treatment In Patients With Pd-L1-Expressing Advanced Non-Small Cell Lung Cancer (Nsclc)
JOURNAL OF THORACIC ONCOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要